Double maintains 2 strategies that include AGIO - Agios Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SYPR | 0.02% | $52.86M | +19.79% | 0.00% |
CPSH | -0.14% | $40.67M | +64.71% | 0.00% |
BPT | -0.15% | $11.00M | -79.19% | 0.00% |
DG | -0.18% | $25.19B | -13.45% | 2.07% |
AWR | 0.23% | $2.94B | +5.29% | 2.44% |
HMY | -0.23% | $8.34B | +46.13% | 1.27% |
ES | 0.28% | $23.28B | +11.73% | 4.65% |
BEKE | 0.38% | $21.25B | +31.02% | 1.99% |
WEC | 0.39% | $32.91B | +31.44% | 3.35% |
BILI | 0.39% | $6.98B | +38.73% | 0.00% |
CYCN | 0.42% | $9.63M | +30.43% | 0.00% |
LQDT | -0.44% | $738.37M | +18.37% | 0.00% |
LNTH | 0.44% | $5.64B | +1.49% | 0.00% |
BVN | 0.55% | $4.10B | -4.72% | 0.00% |
IMDX | -0.67% | $91.52M | +8.47% | 0.00% |
STG | -0.68% | $29.06M | -28.79% | 0.00% |
CPB | 0.70% | $9.18B | -31.87% | 4.94% |
AIFU | -0.76% | $6.13B | +82.50% | 0.00% |
SOHU | 0.82% | $392.95M | -6.11% | 0.00% |
PHYS.U | -0.88% | - | - | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 59.07% | $4.95B | 0.35% |
IBB | 52.78% | $5.36B | 0.45% |
PBE | 51.81% | $223.16M | 0.58% |
IWO | 51.53% | $11.48B | 0.24% |
GNOM | 50.09% | $44.21M | 0.5% |
IWC | 49.95% | $824.65M | 0.6% |
ISCG | 49.83% | $679.06M | 0.06% |
PTH | 49.22% | $100.99M | 0.6% |
XPH | 49.14% | $149.79M | 0.35% |
VBK | 48.73% | $18.97B | 0.07% |
VTWO | 48.70% | $13.29B | 0.07% |
IWM | 48.68% | $64.00B | 0.19% |
KJAN | 48.41% | $289.38M | 0.79% |
PINK | 48.28% | $133.06M | 0.5% |
VXF | 47.87% | $22.24B | 0.05% |
JMOM | 47.79% | $1.70B | 0.12% |
SCHA | 47.69% | $17.26B | 0.04% |
ARKG | 47.51% | $1.05B | 0.75% |
ARKK | 47.33% | $6.89B | 0.75% |
KOMP | 47.13% | $2.28B | 0.2% |
Finnhub
Agios Pharmaceuticals, Inc. added to Russell 2000 Value-Defensive Index...
Finnhub
Agios Pharmaceuticals, Inc. added to Russell 2000 Defensive Index...
Yahoo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is among the best NASDAQ stocks under $50 to buy. On Monday, analysts at TD Cowen reaffirmed their Buy rating on Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), expressing confidence in the company’s mitapivat drug ahead of trial results. The financial services firm believes that the drug will show considerable reductions in vaso-occlusive crises […]
Yahoo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 9, Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) and reduced the price target from $61 to $56. The reiteration comes after the company announced its commercial and distribution agreement […]
SeekingAlpha
Agios Pharmaceuticals is down some 40% since I last looked at this commercial stage biotech. Read the report to find updates on my thesis on the AGIO stock.
Finnhub
Presenter SpeechSalveen Richter Great good morning, everyone, and thank you so much for joining us. We're really pleased to kick off the Goldman Sachs Healthcare Conference with the Agios team. So...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTO | <0.01% | $352.26M | 0.07% |
IBTJ | -0.05% | $685.71M | 0.07% |
LDUR | 0.11% | $929.55M | 0.5% |
JUCY | -0.16% | $271.76M | 0.6% |
TDTT | 0.19% | $2.63B | 0.18% |
FLGV | -0.24% | $1.01B | 0.09% |
USO | 0.25% | $1.18B | 0.6% |
BNO | -0.28% | $103.68M | 1% |
SPTI | -0.30% | $8.78B | 0.03% |
IBTM | -0.54% | $316.18M | 0.07% |
FLMI | -0.66% | $722.98M | 0.3% |
UUP | 0.68% | $237.02M | 0.77% |
TBIL | -0.71% | $5.84B | 0.15% |
IBTL | -0.75% | $380.68M | 0.07% |
BWX | -0.78% | $1.53B | 0.35% |
STXT | 0.79% | $129.73M | 0.49% |
TYA | 0.87% | $152.19M | 0.15% |
USL | 0.89% | $42.26M | 0.85% |
IBTK | -0.89% | $442.63M | 0.07% |
FMHI | 0.92% | $752.95M | 0.7% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LGND | 51.84% | $2.20B | +35.47% | 0.00% |
ZYME | 49.13% | $876.06M | +46.53% | 0.00% |
CTAS | 47.42% | $89.14B | +26.10% | 1.23% |
CRNX | 47.21% | $2.81B | -33.11% | 0.00% |
OCUL | 45.74% | $1.47B | +34.80% | 0.00% |
KRYS | 45.70% | $4.01B | -24.37% | 0.00% |
ROIV | 45.52% | $7.74B | +7.76% | 0.00% |
VRDN | 45.26% | $1.17B | +10.15% | 0.00% |
SNDX | 44.52% | $777.87M | -55.97% | 0.00% |
SYRE | 43.90% | $918.58M | -35.26% | 0.00% |
XENE | 43.62% | $2.49B | -16.90% | 0.00% |
IDYA | 43.58% | $1.87B | -39.13% | 0.00% |
RVMD | 43.26% | $6.88B | -4.90% | 0.00% |
NRIX | 43.13% | $887.38M | -44.23% | 0.00% |
ARWR | 42.74% | $2.22B | -38.13% | 0.00% |
PNFP | 42.67% | $8.50B | +36.88% | 0.84% |
ELVN | 42.54% | $1.22B | -11.51% | 0.00% |
DNLI | 42.23% | $2.05B | -39.28% | 0.00% |
IMVT | 42.22% | $2.75B | -39.02% | 0.00% |
JCI | 42.18% | $69.14B | +58.07% | 1.41% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HSY | -15.38% | $33.83B | -9.16% | 3.28% |
BGS | -11.05% | $350.31M | -45.67% | 18.11% |
CBOE | -11.04% | $23.98B | +34.66% | 1.10% |
ZCMD | -9.00% | $28.79M | -13.64% | 0.00% |
VSTA | -8.62% | $342.46M | +40.00% | 0.00% |
CVM | -7.72% | $12.32M | -93.10% | 0.00% |
CIG.C | -6.83% | $2.64B | +19.84% | 0.00% |
VZ | -6.33% | $178.39B | +2.59% | 6.38% |
AMT | -6.26% | $101.95B | +12.04% | 3.05% |
AWK | -6.23% | $26.90B | +6.78% | 2.27% |
K | -6.14% | $27.41B | +36.96% | 2.88% |
CNC | -6.10% | $26.87B | -18.57% | 0.00% |
LITB | -5.78% | $21.70M | -78.27% | 0.00% |
GFI | -5.47% | $20.47B | +53.49% | 2.38% |
ED | -5.19% | $35.36B | +9.76% | 3.39% |
SPTN | -5.17% | $897.34M | +41.31% | 3.31% |
AEP | -4.51% | $54.73B | +16.78% | 3.58% |
MKTX | -4.50% | $8.23B | +9.48% | 1.37% |
ARRY | -4.14% | $982.40M | -37.23% | 0.00% |
VHC | -3.97% | $45.90M | +59.26% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -37.56% | $165.69M | 0.85% |
BTAL | -36.39% | $296.79M | 1.43% |
TAIL | -35.94% | $99.76M | 0.59% |
IVOL | -14.41% | $351.30M | 1.02% |
FXY | -9.69% | $815.67M | 0.4% |
XHLF | -8.76% | $1.73B | 0.03% |
TBLL | -8.08% | $2.14B | 0.08% |
SCHO | -7.16% | $11.46B | 0.03% |
TPMN | -6.96% | $30.77M | 0.65% |
SHYM | -6.71% | $349.95M | 0.35% |
FTSD | -6.56% | $231.79M | 0.25% |
TFLO | -6.44% | $6.86B | 0.15% |
SPTS | -6.36% | $5.78B | 0.03% |
XONE | -6.18% | $585.86M | 0.03% |
BILS | -5.54% | $3.86B | 0.1356% |
STOT | -5.48% | $253.88M | 0.45% |
UNG | -5.40% | $359.91M | 1.06% |
CLIP | -4.46% | $1.52B | 0.07% |
UTWO | -4.16% | $379.36M | 0.15% |
CTA | -4.05% | $1.06B | 0.76% |
Current Value
$33.511 Year Return
Current Value
$33.511 Year Return